openPR Logo
Press release

Oral Drug Delivery Market 2018: Growth Factors Analysis, By Top Companies: AbbVie, Inc., Amgen, Inc., Catalent Inc, Kemwell Bipharma., Pfizer, Inc., Novartis AG, Biocon, Sanofi, Novo Nordisk A/S. Johnson & Johnson Services, Inc., Roche Ltd., Bayer AG, Ant

08-24-2018 04:11 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Oral Drug Delivery Market

Oral Drug Delivery Market

Global Oral Drug Delivery Market Research Report Forecast 2018-2025 is a valuable source of insightful data for business strategists. It provides the Oral Drug Delivery industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Oral Drug Delivery Market study provides comprehensive data which enhances the understanding, scope and application of this report.

GET FREE SAMPLE REPORT@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-oral-drug-delivery-market

Global Oral Drug Delivery Market is expected to grow significantly during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Oral drug delivery system can be categorized into targeted release formulations, sustained release formulations and immediate release formulations. The immediate release formulations are typically superior to attain rapid onset of action for some drugs like analgesics, antipyretics and vasodilators. Serum concentration is maintained in therapeutic range for longer duration. Drug release rate can be predicted and controlled for distinct time period. Drugs with shorter half-life can be consecutively designed to enhance their duration of action along with the lesser frequency of drug administration and hence better level of patient compliance with minimum wastage of drug.

Major Market Competitors/Players: Global Oral Drug Delivery Market

Global Oral Drug Delivery Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some of the prominent participants operating in this market are:

• AbbVie, Inc.,
• Amgen, Inc.,
• Catalent Inc,
• Kemwell Bipharma.,
• Pfizer, Inc.,
• Novartis AG,
• Biocon,
• Sanofi,
• Novo Nordisk A/S. Johnson & Johnson Services, Inc.,
• Roche Ltd.,
• Bayer AG,
• Antares Pharma, Inc.,
• Becton,
• Dickinson and Company,
• Glaxosmithkline PLC,
• 3M,
• Merck & Co., Inc.,
• Bend Research,
• Endocyte,
• Microchips Inc,
• Pearl Therapeutics Inc,
• Presage Bioscience,
• UCB Group,
• Genentech Inc,
• Polymer Factory,
• Alkermes Inc,
• BIND Biosciences Incand QLT Inc.
• Sanofiothers

Competitive Analysis: Global Oral Drug Delivery Market

The global oral drug delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of oral drug delivery market for global, Europe, North America, Asia Pacific and South America.

Customization With Discount Available On This Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-oral-drug-delivery-market

Major Market Drivers and Restraints:

• Rising prevalence of chronic diseases
• Growth in the biologics market
• Technological advancement and new product launches
• Risk of needle stick injuries and side effects of drugs
• Product recalls

Market Segmentation: Global Oral Drug Delivery Market

The global oral drug delivery market is segmented based on product type, end user, application, distribution channel and geographical segments.

Based on product type, the market is segmented into controlled release and orodispersible tablets (ODT).

On the basis of end users, the market is segmented into hospitals, ambulatory surgical centers, home care settings, diagnostic centers and other.

Based on geography, the market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and Brazil among others.

Key questions answered in the report:

• What will the market growth rate of Oral Drug Delivery Market in 2025?
• What are the key factors driving the Global Oral Drug Delivery Market?
• Who are the key manufacturers in Oral Drug Delivery Market space?
• What are the market opportunities, market risk and market overview of the Oral Drug Delivery Market?
• What are sales, revenue, and price analysis of top manufacturers of Oral Drug Delivery Market?
• Who are the distributors, traders and dealers of Oral Drug Delivery Market?
• What are the Core Materials Market opportunities and threats faced by the vendors in the Oral Drug Delivery Market industry?
• What are sales, revenue, and price analysis by types and applications of Oral Drug Delivery Market?
• What are sales, revenue, and price analysis by regions of Oral Drug Delivery Market industry?

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Read More about This Report@ https://databridgemarketresearch.com/reports/global-oral-drug-delivery-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-281
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oral Drug Delivery Market 2018: Growth Factors Analysis, By Top Companies: AbbVie, Inc., Amgen, Inc., Catalent Inc, Kemwell Bipharma., Pfizer, Inc., Novartis AG, Biocon, Sanofi, Novo Nordisk A/S. Johnson & Johnson Services, Inc., Roche Ltd., Bayer AG, Ant here

News-ID: 1200783 • Views:

More Releases from Data Bridge Market Research

Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 to 2030
Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 …
Vitamin K Market Analysis and Size The essential factors contributing to the growth of the market in the forecast period of 2023 to 2020 include growing demand for vitamin supplements, changing dietary patterns, and rising health consciousness. Data Bridge Market Research analyses that the global vitamin K market, which was USD 841.47 million in 2022, is expected to reach USD 1,410.20 million by 2030, growing at a CAGR of 6.8% during the
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market Analysis and Size Transformers are almost everywhere, and every power and distribution transformer is filled with the dielectric insulating fluid, which consists high resistance to electricity and cools the transformer. The "bio based oil" is the highest growing type segment because it has better resistance to fire as compared to other oil over the forecast period. Furthermore, the growth of electric grids in developing economies and the upgradation
 Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
 Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
Fatty Alcohols Market Analysis and Size The rising demand of hygiene product coupled with growing consumer awareness is anticipated to drive the personal care industry and boost the growth of the fatty alcohols market. Fatty alcohols are used as emollients, emulsifiers and catalytic hydrogenation in cosmetics and beauty products. The "C11-C14 fatty alcohols" is the fastest growing product segment because it is used to produce sodium laureth ether sulphate (SLES), a major foaming agent
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies and Competitive Landscape Top Players Analysis Industry Trends and Forecast
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies an …
An important Gusseted Bags Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Gusseted Bags Market study, the goals of the marketing research are taken into

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug